MRNA — Moderna, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1682852 ·
Last close
$206.80
Market Cap
$82.56B
52W High
$280.80
52W Low
$22.28
ADV30
15,831,337
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,312,000,000 | 994,000,000 | 130,000,000 | 162,000,000 | 13,468,000,000 | 1,195,000,000 | 6,631,000,000 |
| Jun 2026 | 143,000,000 | 50,000,000 | -815,000,000 | -782,000,000 | 10,961,000,000 | 1,723,000,000 | 4,200,000,000 |
| Mar 2026 | 389,000,000 | -566,000,000 | -1,388,000,000 | -1,343,000,000 | 11,488,000,000 | 1,908,000,000 | 4,080,000,000 |
| Dec 2025 | 676,000,000 | 224,000,000 | -857,000,000 | -826,000,000 | 12,338,000,000 | 2,595,000,000 | 3,688,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,073,000,000
Investing CF
$905,000,000
Financing CF
$611,000,000
CapEx
$-171,000,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-7.99
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$5,098,000,000
Inventory
$280,000,000
Receivables
$139,000,000
ST Investments
$3,415,000,000
EBIT TTM
$-3,045,000,000
Pretax Income TTM
$-3,087,000,000
Interest Exp TTM
$42,000,000
Analysts
19
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,228,000,000
EBITDA
$-2,195,000,064
Free Cash Flow
$299,249,984
Enterprise Value
$92,548,497,408
Total Cash
$5,137,999,872
Total Debt
$1,287,000,064
Shares Out
399,235,889
Trailing EPS
$-7.04
Book Value
$21.95
ROE
-39.0%
ROA
-13.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,922,000,000 | -3,074,000,000 | -2,822,000,000 | 12,338,000,000 | 3,688,000,000 | 8,650,000,000 | -1,873,000,000 |
| Dec 2024 | 3,199,000,000 | -3,945,000,000 | -3,561,000,000 | 14,142,000,000 | 3,241,000,000 | 10,901,000,000 | -3,004,000,000 |
| Dec 2023 | 6,754,000,000 | -4,239,000,000 | -4,714,000,000 | 18,426,000,000 | 4,572,000,000 | 13,854,000,000 | -3,118,000,000 |
| Dec 2022 | 18,875,000,000 | 9,420,000,000 | 8,362,000,000 | 25,858,000,000 | 6,735,000,000 | 19,123,000,000 | 4,981,000,000 |
TTM Snapshot
Revenues TTM
$2,228,000,000
NetIncome TTM
$-3,151,000,000
OpCashFlow TTM
—
Assets (Latest)
$10,961,000,000
Forward EPS
$-4.40
Max Pain — expiry 2026-11-27
max pain strike: $225.00 · spot: $196.79 · call oi: 5,906 · put oi: 8,432
Expected Move to 2026-11-27:
±$20.05
(10.19%) —
implied range
$176.74 –
$216.84
· ATM straddle on $195.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARGX | ARGENX SE | $58.92B | $947.52 | — |
| BIIB | BIOGEN INC. | $37.07B | $250.79 | — |
| RVMD | Revolution Medicines, Inc. | $35.19B | $162.69 | — |
| GILD | GILEAD SCIENCES, INC. | $211.18B | $170.26 | — |
| AMGN | AMGEN INC | $247.70B | $457.93 | — |
News headlines (Yahoo Finance, 1h cache)
Global Medical Countermeasures Market 2026: Size, Trends, and Forecast to 2030 | Capitalize on AI, Stockpiling, and Rapid Diagnostics with Pfizer, Moderna, Sanofi, and Emergent
2026-11-18 14:36 · Yahoo
Moderna Targets Year-End Cancer Therapy Filing, Sees Multibillion-Dollar Opportunity
2026-11-18 13:13 · Yahoo
Invesco S&P 500 Equal Weight (RSP) Buys $0.7 Million More PTC on Nov. 16
2026-11-18 11:05 · Yahoo
SLS Joins MRNA And ANL In Biotech’s Top 3 This Year — Here’s How A Late-2025 Bet Could Grow 10x From Here
2026-11-18 02:41 · Yahoo
JPMorgan Still Sees Moderna Overvalued Despite Raising Its Target
2026-11-17 17:45 · Yahoo
Moderna's INT Outlook Strengthens After Phase 3 Melanoma Data, Morgan Stanley Says
2026-11-17 16:22 · Yahoo
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate
2026-11-17 15:02 · Yahoo
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035
2026-11-17 15:00 · Yahoo
At $215, Moderna Stock Already Prices In A Comeback
2026-11-17 10:38 · Yahoo
Is Moderna's Cancer Vaccine a Game Changer for the Stock?
2026-11-16 22:27 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.